SLC27A2 and neoplasm: When A-172 cells with or without ectopic SLC27A2 expression were administered intracranially, the number of viable tumor cells (human Ki-67 positive cells) was significantly reduced in mice with SLC27A2-A-172 cells compared to that in control cells (Fig. 5B).